Case 18-2024: A 64-Year-Old Woman with the Worst Headache of Her Life
A 64-year-old woman was evaluated because of a sudden onset of the worst headache of her life. Computed tomography of the head revealed a...
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy
Second tumors after CAR T-cell therapy are rare, and in one case of a secondary T-cell lymphoma, detailed analysis showed that the genetic construct...
Brigatinib in ALK-Positive ALCL after Failure of Brentuximab Vedotin
Among 15 patients with relapsed ALCL after the failure of brentuximab vedotin therapy, the ALK inhibitor brigatinib led to a complete response in 73%,...
Brief Report: Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy
A patient in whom diarrhea had developed 4 months after BCMA-directed CAR T-cell therapy for myeloma was found to have an indolent CD4+ lymphoma...
T-Cell Cancer after CAR T-Cell Therapy
The last three decades have seen dramatic advances in the use of immunotherapies to treat cancer, primarily in the form of monoclonal antibodies targeting...
